(Q43566394)

24 November 2017

0 references

Onset of therapeutic effect of fluticasone propionate aqueous nasal spray (English)

1 reference

24 November 2017

main subject

fluticasone propionate

1 reference

Meltzer EO

1

1 reference

24 November 2017

Rickard KA

series ordinal

2

1 reference

24 November 2017

Westlund RE

series ordinal

3

1 reference

24 November 2017

Cook CK

series ordinal

4

1 reference

24 November 2017

publication date

1 March 2001

1 reference

Annals of Allergy, Asthma & Immunology

24 November 2017

published in

1 reference

24 November 2017

volume

86

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

286-291

1 reference

Joint Task Force summary statements on Diagnosis and Management of Rhinitis

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Ideal pharmacotherapy for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in children. Fluticasone Propionate Collaborative Pediatric Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963300-5

7 January 2021

10.1016/S1081-1206(10)63300-5

Identifiers

DOI

1 reference

24 November 2017

1 reference